Income Statement Dottikon ES Holding AG

Equities

DESN

CH0582581713

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 09:11:07 2025-06-20 am EDT			5-day change	1st Jan Change
289.00 ^CHF	-0.52%		+0.70%	+30.77%

May. 28	Swiss Market Index Retreats; Dottikon ES Shares Soar	MT
May. 28	Swiss Chemicals Group Dottikon Surges 16% as Fiscal 2025 Profit Jumps Amid Capacity Boost	MT

431987c22c4ec4fa683.0pGYbwitn9Egax3Z10SL_ApiDn54O7WnpMJg5dvbuvo.od7UNmH37eNIHFHp5nb8nUEaV0gXXs_M8vJNoIKNgp6R8KkuXMjtpXRabg

Published financial data: DOTTIKON ES HOLDING AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	219M	252M	319M	326M	385M
Other Revenues, Total	-	-	-	6.71M	7.45M
Total Revenues	219M	252M	319M	333M	393M
Cost of Goods Sold, Total	57.37M	66.68M	105M	121M	140M
Gross Profit	162M	185M	215M	212M	253M
Selling General & Admin Expenses, Total	74.65M	76.53M	84.02M	86.89M	93.32M
Depreciation & Amortization - (IS)	19.15M	21.12M	20.57M	20.64M	22.04M
Other Operating Expenses	5.76M	16.4M	15.64M	13.06M	15.05M
Other Operating Expenses, Total	99.56M	114M	120M	121M	130M
Operating Income	61.96M	71.2M	94.68M	91.17M	122M
Interest Expense, Total	-	-	-302K	-928K	-1.21M
Interest And Investment Income	1K	44K	341K	2.79M	1.31M
Net Interest Expenses	1K	44K	39K	1.86M	102K
Income (Loss) On Equity Invest.	-22K	418K	260K	5K	206K
Currency Exchange Gains (Loss)	6K	-677K	-259K	-225K	-324K
Other Non Operating Income (Expenses)	-63K	-391K	-167K	-15K	-13K
EBT, Excl. Unusual Items	61.89M	70.6M	94.55M	92.8M	122M
Gain (Loss) On Sale Of Assets	-654K	-880K	-337K	-325K	-909K
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	61.23M	69.72M	94.22M	92.47M	121M
Income Tax Expense	8.92M	10.43M	6.5M	11.84M	15.9M
Earnings From Continuing Operations	52.32M	59.29M	87.71M	80.63M	106M
Net Income to Company	52.32M	59.29M	87.71M	80.63M	106M
Net Income - (IS)	52.32M	59.29M	87.71M	80.63M	106M
Net Income to Common Incl Extra Items	52.32M	59.29M	87.71M	80.63M	106M
Net Income to Common Excl. Extra Items	52.32M	59.29M	87.71M	80.63M	106M
Per Share Items
Net EPS - Basic	4.15	4.29	6.35	5.84	7.64
Basic EPS - Continuing Operations	4.15	4.29	6.35	5.84	7.64
Basic Weighted Average Shares Outstanding	12.61M	13.81M	13.81M	13.82M	13.82M
Net EPS - Diluted	4.15	4.29	6.35	5.84	7.64
Diluted EPS - Continuing Operations	4.15	4.29	6.35	5.84	7.64
Diluted Weighted Average Shares Outstanding	12.61M	13.81M	13.81M	13.82M	13.82M
Normalized Basic EPS	3.07	3.2	4.28	4.2	5.54
Normalized Diluted EPS	3.07	3.2	4.28	4.2	5.54
Supplemental Items
EBITDA	80.84M	92.13M	115M	112M	144M
EBITA	61.96M	71.2M	94.68M	91.17M	122M
EBIT	61.96M	71.2M	94.68M	91.17M	122M
EBITDAR	81.06M	92.33M	115M	112M	144M
Effective Tax Rate - (Ratio)	14.56	14.96	6.9	12.81	13.09
Total Current Taxes	8.25M	7.31M	12.46M	12.77M	14.12M
Total Deferred Taxes	667K	3.12M	-5.96M	-925K	1.78M
Normalized Net Income	38.68M	44.12M	59.1M	58M	76.49M
Non-Cash Pension Expense	-	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	18.89M	18.87M	19.82M	21.09M	22.11M
Net Rental Expense, Total	218K	205K	370K	223K	277K
Imputed Operating Lease Interest Expense	-	-	-	20.69K	23.24K
Imputed Operating Lease Depreciation	-	-	-	202K	254K
Maintenance & Repair Expenses, Total	12.4M	13.36M	13.18M	12.09M	14.12M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	185M	142M	189M	181M	148M
Short Term Investments	65M	64.88M	30M	20M	50M
Total Cash And Short Term Investments	250M	207M	219M	201M	198M
Accounts Receivable, Total	50.18M	69.3M	70.51M	54.26M	104M
Other Receivables	2.1M	5.31M	4.77M	9.65M	5.37M
Total Receivables	52.28M	74.61M	75.27M	63.92M	109M
Inventory	102M	143M	167M	168M	194M
Prepaid Expenses	1.74M	2.07M	2.59M	2.44M	2.98M
Other Current Assets, Total	-	-	-	793K	334K
Total Current Assets	406M	426M	464M	436M	504M
Gross Property Plant And Equipment	663M	744M	912M	1.09B	1.19B
Accumulated Depreciation	-348M	-361M	-370M	-385M	-400M
Net Property Plant And Equipment	315M	383M	542M	706M	792M
Long-term Investments	1.25M	1.67M	1.93M	1.93M	2.14M
Other Intangibles, Total	415K	214K	246K	1.9M	2.25M
Other Long-Term Assets, Total	44.52M	47.18M	45.53M	46.56M	49.64M
Total Assets	767M	858M	1.05B	1.19B	1.35B
Liabilities
Accounts Payable, Total	9.82M	11.12M	11.8M	25.54M	20.57M
Accrued Expenses, Total	24.62M	43.2M	86.35M	99.16M	101M
Current Income Taxes Payable	3.03M	1.46M	5.06M	7.48M	9.68M
Unearned Revenue Current, Total	-	-	2K	2K	4K
Other Current Liabilities	36.46M	50.55M	49.9M	38.1M	56.85M
Total Current Liabilities	73.92M	106M	153M	170M	189M
Long-Term Debt	-	-	60M	100M	130M
Deferred Tax Liability Non Current	31.6M	34.52M	28.49M	27.79M	29.54M
Other Non Current Liabilities	5.42M	2.59M	9.52M	8.31M	10.11M
Total Liabilities	111M	143M	251M	306M	358M
Common Stock, Total	140K	140K	140K	140K	140K
Additional Paid In Capital	263M	264M	264M	-	-
Retained Earnings	396M	455M	543M	624M	729M
Treasury Stock	-3.91M	-3.83M	-3.79M	-3.71M	-3.64M
Comprehensive Income and Other	420K	-457K	-1M	266M	266M
Total Common Equity	656M	715M	803M	886M	992M
Total Equity	656M	715M	803M	886M	992M
Total Liabilities And Equity	767M	858M	1.05B	1.19B	1.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	12.68M	13.81M	13.81M	13.82M	13.82M
ECS Total Common Shares Outstanding	12.68M	13.81M	13.81M	13.82M	13.82M
Book Value / Share	51.72	51.77	58.14	64.11	71.79
Tangible Book Value	655M	715M	803M	884M	990M
Tangible Book Value Per Share	51.69	51.76	58.12	63.97	71.62
Total Debt	0	0	60M	100M	130M
Net Debt	-250M	-207M	-159M	-101M	-67.77M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	1.74M	1.64M	2.96M	1.78M	2.22M
Equity Method Investments, Total	1.25M	1.67M	1.93M	1.93M	2.14M
Account Code - Inventory Valuation	3	3	3	6	6
Inventories - Raw Materials, Total	14.13M	26.92M	35.89M	45.26M	43.94M
Inventories - Work In Process, Total	49.95M	54.62M	54.98M	42.93M	71.99M
Inventories - Finished Goods, Total	29.39M	51.36M	62.23M	68.9M	67.73M
Inventories - Others	8.32M	10.03M	14.01M	10.68M	10.3M
Land - (BS)	8.7M	8.7M	8.7M	8.7M	8.7M
Buildings, Total	185M	194M	198M	213M	280M
Machinery, Total	370M	400M	416M	431M	487M
Full Time Employees	639	665	678	726	793
Accumulated Allowance for Doubtful Accounts (Supple)	47K	62K	60K	44K	81K

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	52.32M	59.29M	87.71M	80.63M	106M
Depreciation & Amortization - CF	18.87M	20.92M	20.39M	20.42M	21.7M
Depreciation & Amortization, Total	18.87M	20.92M	20.39M	20.42M	21.7M
Amortization of Deferred Charges, Total - (CF)	273K	200K	185K	219K	342K
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	22K	-418K	-260K	-5K	-206K
Other Operating Activities, Total	1.86M	-681K	719K	2.04M	3.12M
Change In Accounts Receivable	-15.03M	-19.16M	-1.2M	16.27M	-49.5M
Change In Inventories	-23.14M	-41.14M	-24.17M	-667K	-26.2M
Change In Accounts Payable	-1.38M	3.36M	-1.9M	112K	3.14M
Change in Other Net Operating Assets	26.2M	13.84M	8.06M	-16.34M	37.69M
Cash from Operations	60M	36.21M	89.53M	103M	95.67M
Capital Expenditure	-52.35M	-79.06M	-136M	-159M	-126M
Sale of Property, Plant, and Equipment	15K	-	1K	-	23K
Sale (Purchase) of Intangible assets	-27K	-29K	-195K	-1.14M	-763K
Investment in Marketable and Equity Securities, Total	-65M	78K	34.88M	10M	-29.94M
Cash from Investing	-117M	-79.01M	-101M	-150M	-157M
Long-Term Debt Issued, Total	-	-	60M	40M	30M
Total Debt Issued	-	-	60M	40M	30M
Issuance of Common Stock	204M	-	-	-	-
Other Financing Activities, Total	-4.04M	-	-302K	-924K	-1.21M
Cash from Financing	200M	-	59.7M	39.08M	28.79M
Foreign Exchange Rate Adjustments	87K	-410K	-451K	-271K	-308K
Net Change in Cash	142M	-43.2M	47.28M	-8.63M	-32.83M
Supplemental Items
Cash Interest Paid	17K	391K	469K	939K	1.22M
Cash Income Tax Paid (Refund)	7.1M	8.88M	8.85M	10.36M	11.91M
Levered Free Cash Flow	-10.44M	-44.85M	-35.39M	-55.85M	-82.52M
Unlevered Free Cash Flow	-10.44M	-44.85M	-35.2M	-55.27M	-81.76M
Change In Net Working Capital	15.94M	31.4M	-21.44M	-27.22M	53.24M
Net Debt Issued / Repaid	-	-	60M	40M	30M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.16	5.48	6.19	5.07	6.02
Return on Total Capital	7.32	6.49	7.5	6.16	7.26
Return On Equity %	9.89	8.65	11.56	9.55	11.24
Return on Common Equity	9.89	8.65	11.56	9.55	11.24
Margin Analysis
Gross Profit Margin %	73.79	73.53	67.27	63.59	64.38
SG&A Margin	34.1	30.38	26.3	26.1	23.76
EBITDA Margin %	36.93	36.57	36.02	33.51	36.7
EBITA Margin %	28.31	28.26	29.64	27.38	31.17
EBIT Margin %	28.31	28.26	29.64	27.38	31.17
Income From Continuing Operations Margin %	23.9	23.53	27.46	24.21	26.89
Net Income Margin %	23.9	23.53	27.46	24.21	26.89
Net Avail. For Common Margin %	23.9	23.53	27.46	24.21	26.89
Normalized Net Income Margin	17.67	17.51	18.5	17.42	19.48
Levered Free Cash Flow Margin	-4.77	-17.8	-11.08	-16.77	-21.01
Unlevered Free Cash Flow Margin	-4.77	-17.8	-11.02	-16.6	-20.82
Asset Turnover
Asset Turnover	0.35	0.31	0.33	0.3	0.31
Fixed Assets Turnover	0.73	0.72	0.69	0.53	0.52
Receivables Turnover (Average Receivables)	5.13	4.22	4.57	5.23	4.88
Inventory Turnover (Average Inventory)	0.64	0.54	0.67	0.72	0.77
Short Term Liquidity
Current Ratio	5.49	4.01	3.03	2.56	2.67
Quick Ratio	4.09	2.65	1.92	1.55	1.63
Operating Cash Flow to Current Liabilities	0.81	0.34	0.58	0.6	0.51
Days Sales Outstanding (Average Receivables)	71.13	86.55	79.87	69.98	74.84
Days Outstanding Inventory (Average Inventory)	574.03	669.82	541.19	505.51	472
Average Days Payable Outstanding	45.82	35.44	32.51	56.07	50.68
Cash Conversion Cycle (Average Days)	599.35	720.93	588.56	519.42	496.16
Long Term Solvency
Total Debt/Equity	-	-	7.47	11.29	13.1
Total Debt / Total Capital	-	-	6.95	10.14	11.59
LT Debt/Equity	-	-	7.47	11.29	13.1
Long-Term Debt / Total Capital	-	-	6.95	10.14	11.59
Total Liabilities / Total Assets	14.47	16.71	23.82	25.7	26.53
EBIT / Interest Expense	-	-	313.51	98.25	101.5
EBITDA / Interest Expense	-	-	381.01	120.25	119.5
(EBITDA - Capex) / Interest Expense	-	-	-69.94	-51.06	14.77
Total Debt / EBITDA	-	-	0.52	0.9	0.9
Net Debt / EBITDA	-3.09	-2.25	-1.38	-0.9	-0.47
Total Debt / (EBITDA - Capex)	-	-	-2.84	-2.11	7.3
Net Debt / (EBITDA - Capex)	-8.78	-15.82	7.54	2.12	-3.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.25	15.09	26.8	2.18	17.93
Gross Profit, 1 Yr. Growth %	23.86	14.69	14.89	-4.33	19.39
EBITDA, 1 Yr. Growth %	41.33	13.97	24.9	-3.02	29.14
EBITA, 1 Yr. Growth %	60.98	14.91	32.97	-3.7	34.27
EBIT, 1 Yr. Growth %	60.98	14.91	32.97	-3.7	34.27
Earnings From Cont. Operations, 1 Yr. Growth %	57.77	13.33	47.94	-8.08	30.95
Net Income, 1 Yr. Growth %	57.77	13.33	47.94	-8.08	30.95
Normalized Net Income, 1 Yr. Growth %	60.91	14.08	33.93	-1.86	31.89
Diluted EPS Before Extra, 1 Yr. Growth %	56.74	3.45	47.91	-8.11	30.91
Accounts Receivable, 1 Yr. Growth %	42.77	38.12	1.73	-23.04	91.13
Inventory, 1 Yr. Growth %	29.41	40.41	16.91	0.4	15.61
Net Property, Plant and Equip., 1 Yr. Growth %	10.9	21.71	41.6	30.25	12.15
Total Assets, 1 Yr. Growth %	56.53	11.95	22.8	13.1	13.26
Tangible Book Value, 1 Yr. Growth %	63.3	9.06	12.31	10.11	11.99
Common Equity, 1 Yr. Growth %	63.16	9.02	12.31	10.31	12
Cash From Operations, 1 Yr. Growth %	37.29	-39.64	147.23	14.68	-6.82
Capital Expenditures, 1 Yr. Growth %	18.31	51.03	72.27	16.73	-20.55
Levered Free Cash Flow, 1 Yr. Growth %	-28.16	329.6	-21.11	57.82	47.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.16	329.6	-21.53	57.02	47.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.73	20.06	20.8	14.97	9.77
Gross Profit, 2 Yr. CAGR %	20.62	19.19	15.35	6.4	6.88
EBITDA, 2 Yr. CAGR %	43.17	26.91	19.31	10.06	11.91
EBITA, 2 Yr. CAGR %	60.92	36.01	23.61	13.16	13.71
EBIT, 2 Yr. CAGR %	60.92	36.01	23.61	13.16	13.71
Earnings From Cont. Operations, 2 Yr. CAGR %	79.39	33.72	29.49	16.61	9.71
Net Income, 2 Yr. CAGR %	79.39	33.72	29.49	16.61	9.71
Normalized Net Income, 2 Yr. CAGR %	60.83	35.48	23.6	14.65	13.77
Diluted EPS Before Extra, 2 Yr. CAGR %	78.71	27.34	23.7	16.59	9.68
Accounts Receivable, 2 Yr. CAGR %	10.35	40.43	18.54	-11.51	21.29
Inventory, 2 Yr. CAGR %	23.18	34.8	28.12	8.34	7.74
Net Property, Plant and Equip., 2 Yr. CAGR %	9.17	16.18	31.28	35.81	20.86
Total Assets, 2 Yr. CAGR %	28.68	32.38	17.25	17.85	13.18
Tangible Book Value, 2 Yr. CAGR %	33.52	33.45	10.67	11.2	11.04
Common Equity, 2 Yr. CAGR %	33.43	33.37	10.65	11.3	11.15
Cash From Operations, 2 Yr. CAGR %	25.37	-8.97	22.16	68.38	3.37
Capital Expenditures, 2 Yr. CAGR %	4.05	33.67	61.3	41.81	-3.7
Levered Free Cash Flow, 2 Yr. CAGR %	-12	75.68	84.1	11.59	52.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12	75.68	83.61	11	52.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.84	19.48	22.27	15.01	15.94
Gross Profit, 3 Yr. CAGR %	10.41	18.61	18.12	9.45	10.57
EBITDA, 3 Yr. CAGR %	19.51	32.69	26.24	11.35	16.08
EBITA, 3 Yr. CAGR %	25.58	43.83	34.99	13.74	19.8
EBIT, 3 Yr. CAGR %	25.58	43.83	34.99	13.74	19.8
Earnings From Cont. Operations, 3 Yr. CAGR %	26.52	53.93	38.3	15.51	21.21
Net Income, 3 Yr. CAGR %	26.52	53.93	38.3	15.51	21.21
Normalized Net Income, 3 Yr. CAGR %	25.1	43.43	34.96	14.46	20.13
Diluted EPS Before Extra, 3 Yr. CAGR %	26.17	48.94	33.86	12.03	21.18
Accounts Receivable, 3 Yr. CAGR %	-2.38	18.93	26.12	2.65	14.38
Inventory, 3 Yr. CAGR %	24.98	28.67	28.55	18.12	10.71
Net Property, Plant and Equip., 3 Yr. CAGR %	10.77	13.2	24.1	30.94	27.41
Total Assets, 3 Yr. CAGR %	20.49	22.84	29.1	15.85	16.3
Tangible Book Value, 3 Yr. CAGR %	23.14	24.81	25.99	10.48	11.46
Common Equity, 3 Yr. CAGR %	23.11	24.74	25.94	10.54	11.54
Cash From Operations, 3 Yr. CAGR %	15.25	-1.74	27.01	19.61	38.24
Capital Expenditures, 3 Yr. CAGR %	13.95	17.81	45.47	44.82	16.9
Levered Free Cash Flow, 3 Yr. CAGR %	70.45	49.29	34.53	74.89	22.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	70.45	49.29	34.29	74.28	22.16
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.18	10.26	14.72	17.65	17.57
Gross Profit, 5 Yr. CAGR %	11.55	9.8	12.36	13.78	14.16
EBITDA, 5 Yr. CAGR %	19.9	10.97	19.43	23.12	20.3
EBITA, 5 Yr. CAGR %	28.6	16.56	24.79	30.67	26.04
EBIT, 5 Yr. CAGR %	28.6	16.56	24.79	30.67	26.04
Earnings From Cont. Operations, 5 Yr. CAGR %	29.67	21.75	27.7	37.75	26.06
Net Income, 5 Yr. CAGR %	29.67	21.75	27.7	37.75	26.06
Normalized Net Income, 5 Yr. CAGR %	27.83	16.28	24.5	31.14	26.05
Diluted EPS Before Extra, 5 Yr. CAGR %	29.4	19.34	25.17	35.04	23.6
Accounts Receivable, 5 Yr. CAGR %	-0.94	9.97	5.51	5.66	24.17
Inventory, 5 Yr. CAGR %	17.58	25.75	26.23	20.12	19.78
Net Property, Plant and Equip., 5 Yr. CAGR %	10.11	13.03	18.56	21.75	22.8
Total Assets, 5 Yr. CAGR %	17.58	17.67	19.18	20.82	22.48
Tangible Book Value, 5 Yr. CAGR %	17.63	18.13	17.99	19.18	19.79
Common Equity, 5 Yr. CAGR %	17.59	18.1	17.97	19.18	19.8
Cash From Operations, 5 Yr. CAGR %	58.88	-8.68	17.97	21.88	16.96
Capital Expenditures, 5 Yr. CAGR %	31.56	23.2	30.94	26.88	23.34
Levered Free Cash Flow, 5 Yr. CAGR %	2.77	3.44	75.79	32.88	41.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.77	3.44	75.6	32.6	41.27